IL15 and non-small cell lung carcinoma: Further optimization of the constructs might safely regulate the secretion of IL-15 and a clinical trial of NK cells genetically engineered to secrete low concentrations of IL-15 was recently initiated in patients with r/r non-small cell lung cancer (NCT05334329).